Cargando…
CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization
Clustered regularly interspaced short palindromic repeats (CRISPR)-based genomic disruption of vascular endothelial growth factor A (Vegfa) with a single gRNA suppresses choroidal neovascularization (CNV) in preclinical studies, offering the prospect of long-term anti-angiogenesis therapy for neovas...
Autores principales: | Chung, Sook Hyun, Sin, Tzu-Ni, Dang, Brian, Ngo, Taylor, Lo, Therlinder, Lent-Schochet, Daniella, Meleppat, Ratheesh K., Zawadzki, Robert J., Yiu, Glenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114159/ https://www.ncbi.nlm.nih.gov/pubmed/35614998 http://dx.doi.org/10.1016/j.omtn.2022.04.015 |
Ejemplares similares
-
Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023) -
Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal Neovascularization
por: Chung, Sook Hyun, et al.
Publicado: (2020) -
CRISPR Technology for Ocular Angiogenesis
por: Chung, Sook Hyun, et al.
Publicado: (2020) -
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
por: Barth, T., et al.
Publicado: (2019) -
Choroidal Neovascularization Regression on Fluorescein Angiography after VEGF Blockade
por: Do, Diana V., et al.
Publicado: (2012)